Immunoassay Reagent ADVIA Centaur® CA 125 II CLIA Non-Waived For ADVIA Centaur Systems 500 Tests

Features

• For in vitro diagnostic use in the quantitative, serial determination of CA 125 in human serum and plasma (EDTA and lithium heparin) and to aid in the management of patients with ovarian carcinoma using the ADVIA Centaur® CP system
• The test is intended for use as an aid in monitoring patients previously treated for ovarian cancer

More Information

• SDS